AC Immune SA (ACIU) Company Profile & Statistics

AC Immune SA
ACIU
(Nasdaq - US)
N/A
3.35
-0.16 (-4.56%)
in:usd•As of: May 16, 2024 13:35 UTC -4
Open
3.47
High
3.47
Low
3.32

About AC Immune SA

CEO

Andrea Pfeifer

Headquarters

epfl innovation park, building b

lausanne, v8 1015, switzerland

Auditor

PricewaterhouseCoopers SA

Employees

161

Share Holders

250

Website

www.acimmune.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn which are in clinical trial. AC Immune SA is based in Lausanne, Switzerland.

AC Immune SA Statistics

Valuation Measures

Market Capitalization ²	331.32M
Enterprise Value	266.15M
Enterprise Value/EBITDA (ttm)	-3.43
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.69
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-38.84%
Return on Invested Capital (ttm)	-39.62%
Return on Assets (ttm)	-34.30%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-77.68M
Net Income Avi to Common (ttm)	-61.90M
Diluted EPS (ttm)	-0.69

Share Statistics

Beta (5Y Monthly)	1.05
52-Week Change	55.81%
S&P500 52-Week Change	29.21%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	94.35M
% Held by Insiders	4.60%
% Held by Institutions	51.36%

Balance Sheet

Total Cash (mrq)	119.82M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	7.78%
Quick Ratio (mrq)	9.22%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	0.01
Free Cash Flow (ytd)	885.90K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AC Immune SA

Trade With A Regulated Broker